Zhen Ping Zhu

Zhen Ping Zhu

No open positions remaining
61 year
Health Technology
Consumer Services
Commercial Services

Profile

Zhen Ping Zhu is President & Co-Chief Executive Officer at Earendil Labs, Inc. since 2024 and Director at Numab Therapeutics AG since 2018.
Former roles include Director & Deputy General Manager at Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. from 2019 to 2022, Director at Refuge Biotechnologies, Inc., Chief Scientific Officer & President-Research at 3SBio, Inc. from 2017 to 2019, Executive Vice President-Biologics at Kadmon Holdings, Inc., EVP-Global Biologics Research & Development at Kadmon Pharmaceuticals LLC, Executive Vice President-Global Biopharmaceuticals at Kadmon Corp.
LLC from 2010 to 2016, and Vice President at ImClone Systems LLC.
Education includes doctorate degrees from Dalhousie University and Jiangxi Medical College, and graduate studies at Chinese Academy of Medical Sciences and Peking Union Medical College.

Zhen Ping Zhu active positions

CompaniesPositionStart
Director/Board Member 2018-02-28

Former positions of Zhen Ping Zhu

CompaniesPositionEnd
SUNSHINE GUOJIAN PHARMACEUTICAL (SHANGHAI) CO., LTD Chief Tech/Sci/R&D Officer 2022-01-12
3SBIO INC. Chief Tech/Sci/R&D Officer 2019-08-31
KADMON HOLDINGS, INC. Corporate Officer/Principal 2017-01-05
Corporate Officer/Principal 2015-12-31
Director/Board Member -
See the detail of Zhen Ping Zhu's experience

Training of Zhen Ping Zhu

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

42

1st degree connections

12

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies12

Health Technology

Health Technology

Consumer Services

Consumer Services

Consumer Services

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services